Unlock instant, AI-driven research and patent intelligence for your innovation.

Checkpoint kinase 1 inhibitors for potentiation of DNA-damaging agents

A DNA damage agent and inhibitor technology, applied in the field of CHK1 inhibitors, can solve problems such as cancer cell death

Active Publication Date: 2017-04-12
ARRAY BIOPHARMA INC
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Normal cells will still activate other checkpoints and recover, whereas cancer cells deprived of checkpoints will be more likely to die

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0087] Female nude mice were subcutaneously inoculated with 5X10 in 1X PBS (100 μL) 6 HT-29 tumor cells. After 11 days, the mice were randomly divided into 3 groups with an average tumor volume of approximately 300 mm in each group 3 . Sorted animals were administered CPT11 (100 mg / kg; IP) for 24 hours and then challenged with Compound 1 or Compound 2.

[0088] Compound 1 (1 mg / Kg, 3 mg / Kg, 10 mg / Kg, 30 mg / Kg and 100 mg / Kg; PO) was administered and tumors were harvested 2 hours after dosing. Phosphorylation of CHK1(s296) was assessed by immunoblotting and normalized to total ERK expression. Results are expressed as percent control ("POC"). The results are shown in Figure 1.

[0089] Compound 2 (25 mg / kg; PO) was administered, and tumors were harvested at 2 hours, 4 hours, 8 hours and 12 hours after administration. Phosphorylation of CHK1(s296) was assessed by immunoblotting and normalized to total ERK expression. Results are expressed as POC. The results are shown in ...

Embodiment 2

[0091] Female nude mice were subcutaneously inoculated with 5X10 in 1X PBS (100 μL) 6 HT-29 tumor cells. After 20 days, the mice were randomly divided into 3 groups, and the average tumor volume of each group was about 390mm 3 . Female nude mice bearing HT-29 tumors were administered CPT11 (100 mg / kg; IP), and tumors were collected for analysis at 48 hours, 72 hours and 96 hours after administration. Phosphorylation of CHK1 and cdc2 was assessed by immunoblotting and normalized to total ERK expression. Results are expressed as POC. The results are shown in Figures 3 and 4.

Embodiment 3

[0093] Female nude mice were subcutaneously inoculated with 5X10 in 1X PBS (100 μL) 6 HT-29 tumor cells. After 12 days, the mice were randomly divided into 6 groups with an average tumor volume of approximately 250 mm in each group 3 . Sorted animals were administered a single dose of CPT11 (100 mg / kg; IP) for 2 days, followed by Compound 1 (50 mg / kg; PO, BID) for 3 consecutive days either simultaneously or 24 hours after CPT11 administration. Tumor size and animal body weight were measured over the course of the study and the data points are represented in FIG. 5 . Tumor volume was calculated using the following: volume = (width 2 X length) / 2. The results are shown in Figure 5, and the tolerance results are shown in Table 1:

[0094] Table 1

[0095] deal with Maximum weight loss % %mortality rate vehicle 5.5, day 13 0 CPT11 3.9, day 13 0 Compound 1 3.9, day 13 0 Combo at the same time N / A 100 Combo 24 hours delay 18...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

ACHK1 inhibitors are provided for administration to cancer patients to potentiate DNA damaging agents.

Description

technical field [0001] The present invention relates to a CHK1 inhibitor for administration to cancer patients to potentiate DNA damaging agents. Background technique [0002] Checkpoint kinase 1 ("CHK1") is a serine / threonine kinase. CHK1 regulates cell cycle progression and is a major factor in the DNA-damage response in cells. CHK1 inhibitors have been shown to sensitize tumor cells to various genotoxic agents, such as chemotherapy and radiation (Tse, ArchieN., et al., "Targeting Checkpoint Kinase 1 in Cancer Therapeutics" Clin. Cancer Res. 13(7) (2007) 1955-1960). Many tumors have been found to lack the G1 DNA damage checkpoint pathway, resulting in a dependence on the S and G2 checkpoints to repair DNA damage and survive (Janetka, JamesW., et al., "Inhibitors of checkpoint kinases: From discovery to the clinic." drug Discovery & Development Vol.10, No.4(2007)473-486). The S and G2 checkpoints are regulated by CHK1. Inhibition of CHK1 has been shown to abolish t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/437A61K31/4745A61K31/7068A61K45/06A61P35/00
CPCA61K31/437A61K31/4745A61K31/7068A61K45/06A61P35/00A61P35/02A61P43/00A61K2300/00A61K9/0053
Inventor M.J.汉弗莱斯S.L.温斯基
Owner ARRAY BIOPHARMA INC